Evidence map›Paper›PMID 29450976›Full record

Observational studyArthritis care & research2018

High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years.

Claire E H Barber, Orit Schieir, Diane Lacaille, Deborah A Marshall, Cheryl Barnabe, Glen Hazlewood, J Carter Thorne, Vandana Ahluwalia, Susan J Bartlett, Gilles Boire and 8 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Arthritis care & research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Claire E H BarberUniversity of Calgary, Calgary, Alberta, Canada, and Arthritis Research Canada, Richmond, British Columbia, Canada.
Orit SchieirUniversity of Toronto, Toronto, Ontario, Canada.
Diane LacailleArthritis Research Canada, Richmond, and University of British Columbia, Vancouver, British Columbia, Canada.
Deborah A MarshallUniversity of Calgary, Calgary, Alberta, Canada, and Arthritis Research Canada, Richmond, British Columbia, Canada.
Cheryl BarnabeUniversity of Calgary, Calgary, Alberta, Canada, and Arthritis Research Canada, Richmond, British Columbia, Canada.ORCID 0000-0003-3761-237X
Glen HazlewoodUniversity of Calgary, Calgary, Alberta, Canada, and Arthritis Research Canada, Richmond, British Columbia, Canada.
J Carter ThorneSouthlake Regional Health Centre, Newmarket, Ontario, Canada.
Vandana AhluwaliaWilliam Osler Health System, Etobicoke, Ontario, Canada.
Susan J BartlettMcGill University Health Centre, Montreal, Quebec, Canada.
Gilles BoireUniversité de Sherbrooke, Sherbrooke, Quebec, Canada.ORCID 0000-0003-2481-5821
Boulos HaraouiUniversity of Montreal, Montreal, Quebec, Canada.
Carol HitchonUniversity of Manitoba, Winnipeg, Manitoba, Canada.
Edward KeystoneUniversity of Toronto, Toronto, Ontario, Canada.
Diane TinSouthlake Regional Health Centre, Newmarket, Ontario, Canada.
Janet E PopeUniversity of Western Ontario, London, Ontario, Canada.
Lisa DenningWilliam Osler Health System, Etobicoke, Ontario, Canada.
Vivian P BykerkArthritis Research Canada, Richmond, British Columbia, Canada, and Hospital for Special Surgery, New York, New York.
Canadian Early Arthritis Cohort Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess adherence to 3 system-level performance measures in a national early rheumatoid arthritis (RA) cohort.

methodsPatients enrolled in the Canadian Early Arthritis Cohort (2007-2015) who met 1987 or 2010 American College of Rheumatology/European League Against Rheumatism criteria with <1 year of symptom duration and ≥1 year of followup after enrollment were included. Performance measures assessed were the percentage of RA patients seen in yearly followup, and the number of gaps between visits of >12 or >14 months, the percentage of RA patients treated with a disease-modifying antirheumatic drug (DMARD), and days from RA diagnosis to initiation of a DMARD. Results are shown stratified by enrollment year to assess for temporal changes in performance.

resultsA total of 1,763 early RA patients were included (mean age 54 years, 73% female, and 82% white). At enrollment, mean ± SD disease duration was 6 ± 3 months, and Disease Activity Score in 28 joints was 5.1 ± 1.5. Over 8 years, the proportion of patients seen in annual followup declined from 100% to 91%. Over followup, 42% of patients had 0 gaps in care of >12 months, and 64% had 0 gaps >14 months. The percentage of DMARD-treated early RA patients was and remained high (95-87%), and the percentage receiving DMARDs within 14 days of diagnosis was 75%. Median time-to-DMARD therapy was 1 day, indicating DMARDs were initiated at diagnosis (90th percentile 93 days).

conclusionThere was evidence of high adherence to system-level performance measures in this early RA cohort following a protocol. Small declines in performance were noted with increasing length of patient followup. Our findings are useful for performance measure benchmarking.

Indexed as

AdultAgedAntirheumatic AgentsArthritis, RheumatoidCanadaFemaleGuideline AdherenceHumansMaleMiddle AgedProcess Assessment, Health CareProspective StudiesTime FactorsAntirheumatic Agents

Identifiers

PMID29450976
PMCPMC6001563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.